Dr. Gabriel Pardo helped develop the new multiple sclerosis medication Kesimpta and spoke about the drug.
When Covid-19 hit Oklahoma, the state had only minimal testing options available. OMRF and OU joined forces to change that.
The drug treats fast-growing, deadly brain cancers with no effective treatment.
The test is intended for large-scale testing of patients, with the capacity to test 180,000 samples over the next 90 days.
OMRF has entered a license agreement with Shanghai RAAS Blood Products for development of novel hemophilia treatment.